Advances in Clinical Application of Cerebrospinal Fluid Circulating Tumor DNA in Leptomeningeal Met...
Advances in Clinical Application of Cerebrospinal Fluid Circulating Tumor DNA in Leptomeningeal Metastasis of Non-small Cell Lung Cancer
About this item
Full title
Author / Creator
Li, Yubin and Li, Xiaoyan
Publisher
China: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Journal title
Language
Chinese
Formats
Publication information
Publisher
China: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Subjects
More information
Scope and Contents
Contents
Leptomeningeal metastasis (LM) is a lethal complication of malignant tumors, with an incidence rate of 3%-5% among patients with non-small cell lung cancer (NSCLC). LM poses significant challenges in diagnosis, has poor prognosis, limited treatment options, and lacks standardized criteria for evaluating therapeutic efficacy, making it a difficult a...
Alternative Titles
Full title
Advances in Clinical Application of Cerebrospinal Fluid Circulating Tumor DNA in Leptomeningeal Metastasis of Non-small Cell Lung Cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_84b9bf3b4b9e47bb91925ef0b0071877
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_84b9bf3b4b9e47bb91925ef0b0071877
Other Identifiers
ISSN
1009-3419,1999-6187
E-ISSN
1999-6187
DOI
10.3779/j.issn.1009-3419.2024.102.16
